Philip Caenepeel
Ostend, VLG, Belgium
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
Dose-Dependent Effect of the Histamine 1 Receptor Antagonist Ebastine in Patients With Non-Constipated Irritable Bowel Syndrome.
Journal: Neurogastroenterology and motility
Published: October 09, 2025
Belgian consensus on the management of patients with functional dyspepsia.
Journal: Acta gastro-enterologica Belgica
Published: June 12, 2025
The Waiting Room Questionnaire, a Patient-Reported Outcome Instrument Including Pictograms for Facilitating the Diagnosis of Functional Gastrointestinal Disorders.
Journal: Neurogastroenterology and motility
Published: October 19, 2024
Change in fatigue in patients with ulcerative colitis or Crohn's disease initiating biologic therapy.
Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
Published: July 03, 2024
Translocation of black carbon particles to human intestinal tissue.
Journal: EBioMedicine
Published: May 27, 2024
Position statement on how can we can implement the Greendeal in our gastrointestinal and gastrointestinal endoscopy department in Belgium.
Journal: Acta gastro-enterologica Belgica
Published: March 03, 2024
DOMINO trial post hoc analysis: evaluation of the diet effects on symptoms in IBS subtypes.
Journal: Therapeutic advances in gastroenterology
Published: January 17, 2024
Treatment of non-constipated irritable bowel syndrome with the histamine 1 receptor antagonist ebastine: a randomised, double-blind, placebo-controlled trial.
Journal: Gut
Published: November 27, 2023
Belgian consensus on irritable bowel syndrome.
Journal: Acta gastro-enterologica Belgica
Published: June 16, 2022
Last Updated: 09/26/2026